Nevro to Present at BofA Securities 2024 Healthcare Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500, Nasdaq pare declines as AI rout teeters; healthcare, staples gain
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
- Nebius shares sink on CoreWeave's bond yield spike and insider sales
- IonQ prices $2 billion equity offering at $40 per share
- Rocket Lab delays Neutron rocket debut to 2027
- Bloom Energy stock falls as inflation data pressures markets
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
NV5 Global (NVEE) PT Lowered to $107 at BofA Securities
May 13, 2024 9:53 AM EDT(Updated - May 13, 2024 9:55 AM EDT)
BofA Securities analyst Bob Hopkins lowered the price target on NV5 Global (NASDAQ: NVEE) o $107.00 (from $110.00) while maintaining a Neutral rating.
The analyst comments "NV5 reported FQ1 results on May 8th. The positives include organic growth of +8%,... More



